symbol
stringlengths 2
11
| publishedDate
stringlengths 24
24
| title
stringlengths 7
369
| image
stringlengths 0
283
| site
stringclasses 13
values | text
stringlengths 0
503
| url
stringlengths 36
1.1k
| sentiment
stringclasses 3
values | sentimentScore
float64 -1
1
⌀ |
|---|---|---|---|---|---|---|---|---|
ZBRA | 2023-10-03T20:32:28.000Z | Zebra Tech Has To Balance Innovation Against Near-Term Challenges: KeyBanc | benzinga | KeyBanc analyst Ken Newman initiated coverage on Zebra Technologies (NASDAQ: ZBRA) with a SectorWeight rating. Newman views ZBRA as a solid market leader in the Automatic Identification and Data Capture (AIDC) industry, with market solutions in mobile computing, data capture, RFID, barcode scanning and printing, and real-time location systems, to name a few. Also Read: Zebra Technologies Stock Plunges After Q2 Performance: Earnings Miss, Guidance Cut and More ZBRA will drive continued innovatio... | https://www.benzinga.com/news/23/10/35065339/zebra-tech-has-to-balance-innovation-against-near-term-challenges-keybanc | Positive | 0.9015 |
|
VERY | 2023-10-03T20:31:59.000Z | Why Vericity Stock Surged Today | benzinga | Vericity, Inc. (NASDAQ: VERY) shares popped Tuesday after iA Financial Group announced it will acquire the company. What To Know: iA American Holdings, Inc. will acquire Vericity in an all-cash transaction valued at approximately $170 million which is expected to close in the first half of 2024. At the closing of the merger, each issued and outstanding share of Vericity common stock ...Full story available on Benzinga.com... | https://www.benzinga.com/news/23/10/35073464/why-vericity-stock-surged-today | Positive | 0.982 |
|
UEEC | 2023-10-03T20:30:00.000Z | United Health Products Reports on FDA Application Status | globenewswire | MESQUITE, NV, Oct. 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process... | https://www.globenewswire.com/news-release/2023/10/03/2754191/0/en/United-Health-Products-Reports-on-FDA-Application-Status.html | Positive | 0.9938 |
|
OLMA | 2023-10-03T20:30:00.000Z | Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | https://ml.globenewswire.com/Resource/Download/aba52262-f4b6-4253-9fac-9e7a125c04b7 | globenewswire | SAN FRANCISCO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company granted stock options to one new employee to purchase an aggregate of 30,000 shares of the Company's common stock, effective as of October 2, 2023. These awards were approved by the Compensation C... | https://www.globenewswire.com/news-release/2023/10/03/2754190/0/en/Olema-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html | Positive | 0.8974 |
FORA | 2023-10-03T20:30:00.000Z | Forian Inc. Announces Stock Repurchase | https://ml.globenewswire.com/Resource/Download/4c1cd787-012d-4e1c-b45f-3de753020f54 | globenewswire | NEWTOWN, PA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced that it has repurchased an aggregate of 1,604,676 shares of Forian common stock in a privately negotiated transaction at redemption price of $2.15 per share for an aggregate purchase price of approximately $3.45 million. The redeemed shares were cancelled and retired an... | https://www.globenewswire.com/news-release/2023/10/03/2754189/0/en/Forian-Inc-Announces-Stock-Repurchase.html | Positive | 0.9358 |
SPEYF | 2023-10-03T20:30:00.000Z | SPEY RESOURCES CORP. APPOINTS NADER VATANCHI AS CEO | https://ml.globenewswire.com/Resource/Download/413d45a7-21b2-4541-95f3-7f89f15abfcc | globenewswire | Vancouver, British Columbia, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Spey Resources Corp. (CSE: SPEY) (OTC: SPEYF) (FRA: 2JS) ("Spey” or the "Company") is pleased to announce the appointment of Nader Vatanchi as Chief Executive Officer of the Company... | https://www.globenewswire.com/news-release/2023/10/03/2754188/0/en/SPEY-RESOURCES-CORP-APPOINTS-NADER-VATANCHI-AS-CEO.html | Positive | 0.9279 |
CLLS | 2023-10-03T20:30:00.000Z | Monthly information on share capital and company voting rights | https://ml.globenewswire.com/Resource/Download/a84ce25b-a774-4635-9b79-d45241f5decc | globenewswire | (Article 223-16 of General Regulation of the French financial markets authority) (Article 223-16 of General Regulation of the French financial markets authority)... | https://www.globenewswire.com/news-release/2023/10/03/2754187/0/en/Monthly-information-on-share-capital-and-company-voting-rights.html | Positive | 0.891 |
SITC | 2023-10-03T20:30:00.000Z | IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting | https://ml.globenewswire.com/Resource/Download/21813ca0-5b16-4fc8-94c7-b620f00bc20a | globenewswire | NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, announced three poster presentations at the Society for Immunotherapy of Cancer’s 38th Annual Meeting (SITC 2023), to be held in San Diego, California on November 1-5, 2023. Two of the posters will include new in vivo and in vitro data related to IO Biotech’s lead therapeutic cancer vaccine... | https://www.globenewswire.com/news-release/2023/10/03/2754186/0/en/IO-Biotech-Announces-Three-Poster-Presentations-at-the-Society-for-Immunotherapy-of-Cancer-s-SITC-38th-Annual-Meeting.html | Negative | -0.9694 |
FMAO | 2023-10-03T20:30:00.000Z | F&M’s Annual Ohio and Indiana Golf Classics Raise $53,000 for Local Charities | https://ml.globenewswire.com/Resource/Download/6120e8dd-0c4b-493c-b40b-21a9d9dee3d8 | globenewswire | F&M Bank recently held its Annual Charity Golf Classics. Combined, the events raised $53,000 for local charities with record participation and donations... | https://www.globenewswire.com/news-release/2023/10/03/2754185/0/en/F-M-s-Annual-Ohio-and-Indiana-Golf-Classics-Raise-53-000-for-Local-Charities.html | Positive | 0.9922 |
CLLS | 2023-10-03T20:30:00.000Z | Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social | https://ml.globenewswire.com/Resource/Download/a84ce25b-a774-4635-9b79-d45241f5decc | globenewswire | (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)... | https://www.globenewswire.com/news-release/2023/10/03/2754184/0/fr/Information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-d-actions-composant-le-capital-social.html | Negative | -0.0516 |
GAMI | 2023-10-03T20:30:00.000Z | GAMCO Expects to Report Diluted EPS for the Third Quarter 2023 of $0.49 to $0.53 Per Share | https://ml.globenewswire.com/Resource/Download/f4d39d2f-bfd5-4936-b6c7-89c59f441a21 | globenewswire | GREENWICH, Conn., Oct. 03, 2023 (GLOBE NEWSWIRE) -- GAMCO Investors, Inc. (“GAMI”) (OTCQX: GAMI) announced today that assets under management were $29.1 billion at September 30, 2023 as compared to $27.6 billion at September 30, 2022... | https://www.globenewswire.com/news-release/2023/10/03/2754183/0/en/GAMCO-Expects-to-Report-Diluted-EPS-for-the-Third-Quarter-2023-of-0-49-to-0-53-Per-Share.html | Positive | 0.9803 |
MKSI | 2023-10-03T20:30:00.000Z | MKS Instruments Completes Repricing of Secured Term Loan B | https://ml.globenewswire.com/Resource/Download/a922cdbe-9964-4f52-86d5-ff5e42639bb0 | globenewswire | ANDOVER, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, announced today that it successfully completed the repricing of its existing $3.6 billion secured tranche B term loan. The lenders have agreed to an amendment that results in a reduction of the interest rate for the tranche B term loans from SOFR plus a credit spread adjustment plus 275 basis points to SOFR plus 250 basis points. The repri... | https://www.globenewswire.com/news-release/2023/10/03/2754182/16396/en/MKS-Instruments-Completes-Repricing-of-Secured-Term-Loan-B.html | Positive | 0.9974 |
WNC | 2023-10-03T20:30:00.000Z | Wabash Schedules Third Quarter 2023 Earnings Conference Call | https://ml.globenewswire.com/Resource/Download/a948ef43-c6d6-40aa-b541-91478470fa22 | globenewswire | LAFAYETTE, Ind., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Wabash (NYSE: WNC) today announced that it will webcast its quarterly earnings conference call to review and discuss its financial results for the third quarter 2023 on Wednesday, October 25, 2023 beginning at 12:00 p.m. ET... | https://www.globenewswire.com/news-release/2023/10/03/2754181/10640/en/Wabash-Schedules-Third-Quarter-2023-Earnings-Conference-Call.html | Positive | 0.8957 |
DEA | 2023-10-03T20:29:47.000Z | 3 Explosive Cannabis Stocks That Will Make Early Investors Rich | investorplace | While the adult botanical industry presents high risks, regulatory momentum may bolster the case of cannabis stocks to make you rich. Specifically, a recent report from the Department of Health and Human Services (HHS) recommended that the U.S. Drug Enforcement Administration (DEA) reschedule marijuana from its present Schedule I status to Schedule III. Moreover, the impetus of this proposal stems from a U.S. Food and Drug Administration (FDA) review of marijuana, which itself represented a requ... | https://investorplace.com/2023/10/3-explosive-cannabis-stocks-that-will-make-early-investors-rich/ | Positive | 0.9986 |
|
HHS | 2023-10-03T20:29:47.000Z | 3 Explosive Cannabis Stocks That Will Make Early Investors Rich | investorplace | While the adult botanical industry presents high risks, regulatory momentum may bolster the case of cannabis stocks to make you rich. Specifically, a recent report from the Department of Health and Human Services (HHS) recommended that the U.S. Drug Enforcement Administration (DEA) reschedule marijuana from its present Schedule I status to Schedule III. Moreover, the impetus of this proposal stems from a U.S. Food and Drug Administration (FDA) review of marijuana, which itself represented a requ... | https://investorplace.com/2023/10/3-explosive-cannabis-stocks-that-will-make-early-investors-rich/ | Positive | 0.9986 |
|
BA | 2023-10-03T20:28:59.000Z | Boeing Stock Rises Amid Big 787 Order But Remains In Sharp Decline | https://media.zenfs.com/en/ibd.com/9c95147c22afba1718f50ffc3121b784 | finance | Boeing (BA) received a big 787 Dreamliner order and reportedly plans record production of its bestselling 737 jet as air travel rebounds. Boeing stock edged up Tuesday near multimonth lows. X United Orders 110 Boeing, Airbus Jets Late Tuesday, United Airlines (UA) announced an order for 110 aircraft, including 50 Boeing Dreamliner widebody jets. | https://www.investors.com/news/dow-jones-boeing-stock-rises-amid-big-787-order-but-remains-in-brutal-decline/?src=A00220&yptr=yahoo | Positive | 0.5422 |
ESM | 2023-10-03T20:27:00.000Z | Euro Sun Mining Settles Convertible Security Funding Agreement in Full | https://ml.globenewswire.com/Resource/Download/d660df0b-8246-4b8e-ad60-69f190565446 | globenewswire | TORONTO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Euro Sun Mining Inc., (TSX: ESM) (“Euro Sun” or the “Company”) announces that it has agreed to settle the outstanding portion of the convertible security funding agreement (the “CFSA”) with Lind Global Fund II, LP (“Lind”) in full... | https://www.globenewswire.com/news-release/2023/10/03/2754180/0/en/Euro-Sun-Mining-Settles-Convertible-Security-Funding-Agreement-in-Full.html | Positive | 0.9939 |
BROG | 2023-10-03T20:24:00.000Z | GULFNAV Submits Proposal to Acquire All of the Businesses and Assets of Brooge Energy Limited | https://ml.globenewswire.com/Resource/Download/430dd928-7ced-465b-b290-81726d3bb574 | globenewswire | NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Brooge Energy Ltd, (“Brooge Energy” or the “Company”) (NASDAQ: BROG), a Cayman Islands-based infrastructure provider, which is currently engaged in clean petroleum products and biofuels and crude oil storage and related services, today announced receiving a formal proposal submitted by Gulf Navigation Holdings PJSC (“GULFNAV”), the Dubai Financial Market listed maritime and shipping company, to acquire fully all of the businesses and assets from Bro... | https://www.globenewswire.com/news-release/2023/10/03/2754179/0/en/GULFNAV-Submits-Proposal-to-Acquire-All-of-the-Businesses-and-Assets-of-Brooge-Energy-Limited.html | Positive | 0.9954 |
XLU | 2023-10-03T20:19:13.000Z | Utility stocks take a beating amid rising rates | https://s.yimg.com/os/creatr-uploaded-images/2023-10/9381b930-621d-11ee-97f7-377ed1e3357f | finance | Utility stocks took a breather on Tuesday following the sector's worst daily performance since April 2020. The SPDR S&P 500 Utility Sector ETF (XLU) fell 4% on Monday and recovered to end the next day higher. Year to date the ETF is down a whopping 21%. | https://finance.yahoo.com/news/utility-stocks-take-a-beating-amid-rising-rates-201913038.html | Positive | 0.9935 |
LIFW | 2023-10-03T20:16:00.000Z | LifeWallet Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement | https://ml.globenewswire.com/Resource/Download/2f5d83c0-000a-4595-836c-a845a14cf88d | globenewswire | LifeWallet Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement... | https://www.globenewswire.com/news-release/2023/10/03/2754176/0/en/LifeWallet-Announces-Reverse-Stock-Split-to-Regain-Compliance-with-Nasdaq-s-Minimum-Bid-Price-Requirement.html | Positive | 0.9965 |
SYBX | 2023-10-03T20:15:00.000Z | Synlogic Announces Closing of $21.0 Million Underwritten Public Offering | https://ml.globenewswire.com/Resource/Download/caca2307-5f54-4b52-8b52-fcfc3dbb7874 | globenewswire | CAMBRIDGE, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced the closing of its previously announced underwritten public offering... | https://www.globenewswire.com/news-release/2023/10/03/2754173/0/en/Synlogic-Announces-Closing-of-21-0-Million-Underwritten-Public-Offering.html | Positive | 0.9878 |
CODI | 2023-10-03T20:15:00.000Z | Compass Diversified Declares Third Quarter 2023 Distributions on Common and Series A, B and C Preferred Shares | https://ml.globenewswire.com/Resource/Download/ee5b08a2-3e90-4882-8700-a887f6890185 | globenewswire | WESTPORT, Conn., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today that its Board of Directors (the “Board”) has declared a quarterly cash distribution of $0.25 per share on the Company’s common shares (the “Common Shares”). The distribution for the three months ended September 30, 2023 is payable on October 26, 2023 to all holders of record of Common Shares as of October 19, 2023... | https://www.globenewswire.com/news-release/2023/10/03/2754172/0/en/Compass-Diversified-Declares-Third-Quarter-2023-Distributions-on-Common-and-Series-A-B-and-C-Preferred-Shares.html | Positive | 0.9968 |
BKH | 2023-10-03T20:15:00.000Z | Black Hills Corp. Schedules 2023 Third Quarter Earnings Release and Conference Call | https://ml.globenewswire.com/Resource/Download/56b34e64-17c6-4ecf-a4f6-b7848f82cfeb | globenewswire | RAPID CITY, S.D., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Black Hills Corp. (NYSE: BKH) will announce its 2023 third quarter earnings after the market closes Wednesday, Nov. 1, 2023, and will host a live conference call and webcast at 11 a.m. EDT on Thursday, Nov. 2, 2023, to discuss the company’s financial results... | https://www.globenewswire.com/news-release/2023/10/03/2754175/10381/en/Black-Hills-Corp-Schedules-2023-Third-Quarter-Earnings-Release-and-Conference-Call.html | Positive | 0.9393 |
UNIT | 2023-10-03T20:15:00.000Z | Uniti Group Inc. To Report Third Quarter 2023 Financial Results and Host Conference Call | https://ml.globenewswire.com/Resource/Download/b065ce09-4401-49b3-a72d-688f19428158 | globenewswire | LITTLE ROCK, Ark., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that it will report its third quarter 2023 financial results prior to the opening of trading on the Nasdaq Stock Exchange on November 2, 2023. A conference call to discuss those earnings will be held the same day at 8:30 AM Eastern Time... | https://www.globenewswire.com/news-release/2023/10/03/2754174/35697/en/Uniti-Group-Inc-To-Report-Third-Quarter-2023-Financial-Results-and-Host-Conference-Call.html | Positive | 0.9118 |
MDLZ | 2023-10-03T20:14:39.000Z | Retail Resilience: 7 Consumer Goods Stocks to Buy to Weather the Storm | investorplace | Although investors have enjoyed another strong season of returns in the equities market, it may be time to consider more reliable consumer goods stocks to buy. Primarily, the sentiment pivot on Wall Street suggests that surviving an onslaught – rather than thriving amid tailwinds – may be the name of the game. Naturally, the first clue stems from the S&P 500 index. Up until the end of July, circumstances appear quite robust for the benchmark gauge of market health. However, since the aforementio... | https://investorplace.com/2023/10/retail-resilience-7-consumer-goods-stocks-to-buy-to-weather-the-storm/ | Positive | 0.9993 |
|
CL | 2023-10-03T20:14:39.000Z | Retail Resilience: 7 Consumer Goods Stocks to Buy to Weather the Storm | investorplace | Although investors have enjoyed another strong season of returns in the equities market, it may be time to consider more reliable consumer goods stocks to buy. Primarily, the sentiment pivot on Wall Street suggests that surviving an onslaught – rather than thriving amid tailwinds – may be the name of the game. Naturally, the first clue stems from the S&P 500 index. Up until the end of July, circumstances appear quite robust for the benchmark gauge of market health. However, since the aforementio... | https://investorplace.com/2023/10/retail-resilience-7-consumer-goods-stocks-to-buy-to-weather-the-storm/ | Positive | 0.9993 |
|
KO | 2023-10-03T20:14:39.000Z | Retail Resilience: 7 Consumer Goods Stocks to Buy to Weather the Storm | investorplace | Although investors have enjoyed another strong season of returns in the equities market, it may be time to consider more reliable consumer goods stocks to buy. Primarily, the sentiment pivot on Wall Street suggests that surviving an onslaught – rather than thriving amid tailwinds – may be the name of the game. Naturally, the first clue stems from the S&P 500 index. Up until the end of July, circumstances appear quite robust for the benchmark gauge of market health. However, since the aforementio... | https://investorplace.com/2023/10/retail-resilience-7-consumer-goods-stocks-to-buy-to-weather-the-storm/ | Positive | 0.9993 |
|
PG | 2023-10-03T20:14:39.000Z | Retail Resilience: 7 Consumer Goods Stocks to Buy to Weather the Storm | investorplace | Although investors have enjoyed another strong season of returns in the equities market, it may be time to consider more reliable consumer goods stocks to buy. Primarily, the sentiment pivot on Wall Street suggests that surviving an onslaught – rather than thriving amid tailwinds – may be the name of the game. Naturally, the first clue stems from the S&P 500 index. Up until the end of July, circumstances appear quite robust for the benchmark gauge of market health. However, since the aforementio... | https://investorplace.com/2023/10/retail-resilience-7-consumer-goods-stocks-to-buy-to-weather-the-storm/ | Positive | 0.9993 |
|
CMRE | 2023-10-03T20:12:00.000Z | Costamare Inc. Announces Election of Class I Director at 2023 Annual Meeting of Stockholders | https://ml.globenewswire.com/Resource/Download/24e05312-cb08-40c5-a0ab-41a695f945bc | globenewswire | MONACO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Costamare Inc. (the “Company”) (NYSE: CMRE), an international owner and provider of containerships and dry bulk vessels for charter, announced the election of one Class I director at the Company’s virtual annual meeting of stockholders held today... | https://www.globenewswire.com/news-release/2023/10/03/2754171/0/en/Costamare-Inc-Announces-Election-of-Class-I-Director-at-2023-Annual-Meeting-of-Stockholders.html | Positive | 0.3612 |
PFLT | 2023-10-03T20:05:51.000Z | PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share | /next-assets/images/schema-image-default.png | benzinga | MIAMI, Oct. 03, 2023 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE:PFLT) (TASE: PFLT) declares its monthly distribution for October 2023 of $0.1025 per share, payable on November 1, 2023 to stockholders of record as of October 17, 2023. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in th... | https://www.benzinga.com/pressreleases/23/10/g35072429/pennantpark-floating-rate-capital-ltd-announces-monthly-distribution-of-0-1025-per-share | Positive | 0.9765 |
GLBS | 2023-10-03T20:05:00.000Z | Globus Maritime Limited Regains Compliance with NASDAQ’s Minimum Closing Bid Price | https://ml.globenewswire.com/Resource/Download/9ccdd172-9c22-4dbe-a6c8-553310255e62 | globenewswire | ATHENS, Greece, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Globus Maritime Limited ("Globus" or the “Company,") (NASDAQ: GLBS), a dry bulk shipping company, announced today that it has received a letter from NASDAQ, indicating that the Company has regained compliance with the $1.00 per share minimum closing bid price requirement for continued listing on the NASDAQ Capital Market, pursuant to the NASDAQ marketplace rules. For at least 10 consecutive business days from September 18 to September 29, 2023,... | https://www.globenewswire.com/news-release/2023/10/03/2754167/0/en/Globus-Maritime-Limited-Regains-Compliance-with-NASDAQ-s-Minimum-Closing-Bid-Price.html | Negative | -0.2353 |
HTCR | 2023-10-03T20:05:00.000Z | HeartCore Signs Eleventh Go IPO Contract | https://ml.globenewswire.com/Resource/Download/4d579f1f-fd68-4e94-9191-206a65264a19 | globenewswire | NEW YORK and TOKYO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced that it has signed an agreement (“Consulting Agreement”) with GATES GROUP Inc. (“GATES GROUP”) for its eleventh Go IPO consulting service win... | https://www.globenewswire.com/news-release/2023/10/03/2754166/0/en/HeartCore-Signs-Eleventh-Go-IPO-Contract.html | Positive | 0.9944 |
OSA | 2023-10-03T20:05:00.000Z | ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference | https://ml.globenewswire.com/Resource/Download/ff5c3fcc-94eb-4048-8dad-e08f8c18069a | globenewswire | PLEASANTON, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), today announces management’s participation in the 2023 Roth Capital Healthcare Opportunities Conference at the Yale Club in New York City on October 12, 2023... | https://www.globenewswire.com/news-release/2023/10/03/2754165/0/en/ProSomnus-Announces-Participation-in-the-2023-Roth-Capital-Healthcare-Opportunities-Conference.html | Positive | 0.9403 |
IGMS | 2023-10-03T20:05:00.000Z | IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors | https://ml.globenewswire.com/Resource/Download/312125d7-48ef-48f1-aa8e-a7532c2f21e8 | globenewswire | MOUNTAIN VIEW, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Michael Loberg, Ph.D. has retired from its Board of Directors, including as Chairman, effective October 3, 2023. Dr. Loberg has served as a member of the IGM Biosciences Board of Directors since 2015 and as Chairman of the Board since 2018... | https://www.globenewswire.com/news-release/2023/10/03/2754164/0/en/IGM-Biosciences-Announces-Retirement-of-Chairman-Michael-Loberg-Ph-D-from-Board-of-Directors-and-Appointment-of-Elizabeth-H-Z-Thompson-Ph-D-to-Board-of-Directors.html | Positive | 0.9982 |
ICU | 2023-10-03T20:05:00.000Z | SeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device Exemption | https://ml.globenewswire.com/Resource/Download/82197c62-f6f0-4c40-b867-4d7589f2180d | globenewswire | Company to finalize labeling with FDA Approvable Letter expected within a month... | https://www.globenewswire.com/news-release/2023/10/03/2754163/0/en/SeaStar-Medical-Provides-Regulatory-Update-Regarding-Selective-Cytopheretic-Device-Use-in-Pediatric-Acute-Kidney-Injury-Under-a-Humanitarian-Device-Exemption.html | Positive | 0.9535 |
PHXM | 2023-10-03T20:05:00.000Z | PHAXIAM Therapeutics et Vetophage annoncent une collaboration de recherche stratégique | https://ml-eu.globenewswire.com/Resource/Download/a0718b1d-a228-44cf-9879-936caaba20fa | globenewswire | PHAXIAM Therapeutics et Vetophage annoncent une collaboration de recherche stratégique... | https://www.globenewswire.com/news-release/2023/10/03/2754162/0/fr/PHAXIAM-Therapeutics-et-Vetophage-annoncent-une-collaboration-de-recherche-strat%C3%A9gique.html | Positive | 0.5267 |
PHXM | 2023-10-03T20:05:00.000Z | PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration | https://ml-eu.globenewswire.com/Resource/Download/a0718b1d-a228-44cf-9879-936caaba20fa | globenewswire | PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration... | https://www.globenewswire.com/news-release/2023/10/03/2754162/0/en/PHAXIAM-Therapeutics-and-Vetophage-Announce-Strategic-Research-Collaboration.html | Positive | 0.9966 |
ETNB | 2023-10-03T20:05:00.000Z | 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | https://ml.globenewswire.com/Resource/Download/b9bcc0cc-5a8f-4148-92e4-e6a6ed503a9c | globenewswire | SAN FRANCISCO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 116,000 shares of the Company’s common stock to four new em... | https://www.globenewswire.com/news-release/2023/10/03/2754161/0/en/89bio-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html | Positive | 0.9833 |
TERN | 2023-10-03T20:05:00.000Z | Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) | https://ml.globenewswire.com/Resource/Download/00cb412c-d8d1-4c3f-9839-803cd3024504 | globenewswire | FOSTER CITY, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, non-alcoholic steatohepatitis (NASH) and obesity, today announced that it has granted as of October 1, 2023 equity inducement awards to two new non-executive employees under the terms of the 2022 Employment Inducement Aw... | https://www.globenewswire.com/news-release/2023/10/03/2754160/0/en/Terns-Pharmaceuticals-Reports-Inducement-Grants-to-New-Employees-Under-Nasdaq-Listing-Rule-5635-C-4.html | Positive | 0.9747 |
CVLG | 2023-10-03T20:05:00.000Z | Covenant Logistics Group, Inc. Announces Timing Of Second Quarter Earnings Release And Conference Call | https://ml.globenewswire.com/Resource/Download/5533ca85-a2a0-4b72-8889-d4e53ff7ee71 | globenewswire | CHATTANOOGA, Tenn., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Covenant Logistics Group, Inc. (Nasdaq/GS: CVLG) announced its plans to release its second quarter earnings after 4:00 p.m. Eastern time on Wednesday, October 25, 2023. Covenant Logistics Group, Inc. will hold a live conference call to discuss its second quarter earnings release on Thursday, October 26, 2023, at 10:00 a.m. Eastern time. Individuals with questions may dial in at 877-550-1505 (U.S./Canada) and 0800-524-4760 (International). A... | https://www.globenewswire.com/news-release/2023/10/03/2754159/10462/en/Covenant-Logistics-Group-Inc-Announces-Timing-Of-Second-Quarter-Earnings-Release-And-Conference-Call.html | Positive | 0.8934 |
LRMR | 2023-10-03T20:05:00.000Z | Larimar Therapeutics Appoints Dr. Jeffery W. Sherman to its Board of Directors | https://ml.globenewswire.com/Resource/Download/b02e1010-493d-4ec7-8523-c59602684d09 | globenewswire | BALA CYNWYD, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the appointment of Jeffrey W. Sherman, M.D., F.A.C.P. to the Company’s Board of Directors, effective today. Dr. Sherman, currently Executive Vice President, Chief Medical Officer (CMO) at Horizon Therapeutics Public Limited Company, has over 20 years of executive experience i... | https://www.globenewswire.com/news-release/2023/10/03/2754158/0/en/Larimar-Therapeutics-Appoints-Dr-Jeffery-W-Sherman-to-its-Board-of-Directors.html | Positive | 0.9447 |
PNNT | 2023-10-03T20:05:00.000Z | PennantPark Investment Corporation Announces Monthly Distribution of $0.07 per Share | https://ml.globenewswire.com/Resource/Download/0263b9d1-f595-4f23-b141-65a16f39b514 | globenewswire | MIAMI, Oct. 03, 2023 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) declares its monthly distribution for October 2023 of $0.07 per share, payable on November 1, 2023 to stockholders of record as of October 17, 2023. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodi... | https://www.globenewswire.com/news-release/2023/10/03/2754157/9057/en/PennantPark-Investment-Corporation-Announces-Monthly-Distribution-of-0-07-per-Share.html | Positive | 0.9349 |
PFLT | 2023-10-03T20:05:00.000Z | PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share | https://ml.globenewswire.com/Resource/Download/6fa3e428-a280-4181-8dd7-60d18f2ded15 | globenewswire | MIAMI, Oct. 03, 2023 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) (TASE: PFLT) declares its monthly distribution for October 2023 of $0.1025 per share, payable on November 1, 2023 to stockholders of record as of October 17, 2023. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in th... | https://www.globenewswire.com/news-release/2023/10/03/2754168/0/en/PennantPark-Floating-Rate-Capital-Ltd-Announces-Monthly-Distribution-of-0-1025-per-Share.html | Positive | 0.9707 |
CMO | 2023-10-03T20:05:00.000Z | Larimar Therapeutics Appoints Dr. Jeffery W. Sherman to its Board of Directors | /next-assets/images/schema-image-default.png | benzinga | BALA CYNWYD, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. ("Larimar") (NASDAQ:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the appointment of Jeffrey W. Sherman, M.D., F.A.C.P. to the Company's Board of Directors, effective today. Dr. Sherman, currently Executive Vice President, Chief Medical Officer (CMO) at Horizon Therapeutics Public Limited Company, has over 20 years of executive experience i... | https://www.benzinga.com/pressreleases/23/10/g35072387/larimar-therapeutics-appoints-dr-jeffery-w-sherman-to-its-board-of-directors | Positive | 0.9447 |
OSA | 2023-10-03T20:05:00.000Z | ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference | /next-assets/images/schema-image-default.png | benzinga | PLEASANTON, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the "Company"), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea ("OSA"), today announces management's participation in the 2023 Roth Capital Healthcare Opportunities Conference at the Yale Club in New York City on October 12, 2023. ProSomnus' Chief Executive Officer, Len Liptak, and Chief Financial Officer, Brian Dow, will deliver a presentation and engage ...Full story available on Be... | https://www.benzinga.com/pressreleases/23/10/g35072390/prosomnus-announces-participation-in-the-2023-roth-capital-healthcare-opportunities-conference | Positive | 0.9403 |
PHXM | 2023-10-03T20:05:00.000Z | PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration | /next-assets/images/schema-image-default.png | benzinga | PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration Strategic research partnership between PHAXIAM Therapeutics and Vetophage, a biotechnology company specialized in veterinary phage therapy Combining expertise in the research of new phages and phage endolysins that could be applied to human health Exclusive phage and endolysin licensing options in human health for PHAXIAM Therapeutics Lyon (France) and Cambridge (MA, US), October 03, 2023 – 10:05 pm CEST – PHAXIAM T... | https://www.benzinga.com/pressreleases/23/10/g35072395/phaxiam-therapeutics-and-vetophage-announce-strategic-research-collaboration | Positive | 0.9966 |
UPWK | 2023-10-03T20:04:00.000Z | Upwork to Report Third Quarter 2023 Financial Results on November 7, 2023 | https://ml.globenewswire.com/Resource/Download/dc149cec-2301-4639-8f73-0732e0b55800 | globenewswire | SAN FRANCISCO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the world’s largest1 work marketplace that connects businesses with independent talent from across the globe, today announced that it will report its financial results for the third quarter of 2023 on Tuesday, November 7, 2023 after market close. The company will host a Q&A conference call to discuss these results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day... | https://www.globenewswire.com/news-release/2023/10/03/2754155/0/en/Upwork-to-Report-Third-Quarter-2023-Financial-Results-on-November-7-2023.html | Positive | 0.9493 |
NXU | 2023-10-03T20:01:00.000Z | Nxu One Megawatt+ Charging System Delivers 1.6MWh and Demonstrates Impressive Utilization Rate During First Weekend of Field Trials | https://ml.globenewswire.com/Resource/Download/ebc66fd7-dccb-42e1-b519-04ca550b637f | globenewswire | New Introductory Pricing Offers Customers Charging for 20 Cents Per kWh New Introductory Pricing Offers Customers Charging for 20 Cents Per kWh... | https://www.globenewswire.com/news-release/2023/10/03/2754149/0/en/Nxu-One-Megawatt-Charging-System-Delivers-1-6MWh-and-Demonstrates-Impressive-Utilization-Rate-During-First-Weekend-of-Field-Trials.html | Positive | 0.9824 |
VOR | 2023-10-03T20:01:00.000Z | Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | https://ml.globenewswire.com/Resource/Download/dde67700-b1b4-40c4-b930-13bd71804762 | globenewswire | CAMBRIDGE, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of October 1, 2023, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 19,250 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 28,876 shares of Vor Bio’s common stock to five newly hired employees. The foregoing... | https://www.globenewswire.com/news-release/2023/10/03/2754148/0/en/Vor-Bio-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html | Positive | 0.9812 |
CBNK | 2023-10-03T20:01:00.000Z | Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution | https://ml.globenewswire.com/Resource/Download/b4204738-c930-4421-a9eb-e325fe3060ea | globenewswire | TORONTO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF has declared a monthly cash distribution in the amount of $0.058333 per unit, payable on November 7, 2023 to unitholders of record on October 31, 2023... | https://www.globenewswire.com/news-release/2023/10/03/2754147/0/en/Mulvihill-Canadian-Bank-Enhanced-Yield-ETF-Declares-Monthly-Distribution.html | Positive | 0.685 |
CEO | 2023-10-03T19:45:00.000Z | 1 Easy Way to Make $2,500 in Dividends Every Year | fool | Canadians can easily make $2,500 in passive income yearly at less capital outlay from a high-yield dividend stock. The post 1 Easy Way to Make $2,500 in Dividends Every Year appeared first on The Motley Fool Canada... | https://www.fool.ca/2023/10/03/1-easy-way-to-make-2500-in-dividends-every-year/ | Positive | 0.9894 |
|
VZ | 2023-10-03T19:42:00.000Z | Verizon continues offering customers exclusive savings on sports and entertainment with newest offer | https://ml.globenewswire.com/Resource/Download/e797a73c-ce36-447f-bf12-b80cc2238f0d | globenewswire | Get Netflix Premium and NFL+ Premium for just $25 per month on +play. And, customers with myPlan can also save even more on subscriptions they love Get Netflix Premium and NFL+ Premium for just $25 per month on +play. And, customers with myPlan can also save even more on subscriptions they love... | https://www.globenewswire.com/news-release/2023/10/03/2754130/0/en/Verizon-continues-offering-customers-exclusive-savings-on-sports-and-entertainment-with-newest-offer.html | Positive | 0.9982 |
EPS | 2023-10-03T19:30:00.000Z | Where to Invest in Oil Stocks in October 2023 | fool | Suncor Energy is an oil stock to invest in today, as its strong balance sheet and cash flows enable it to thrive in this environment. The post Where to Invest in Oil Stocks in October 2023 appeared first on The Motley Fool Canada... | https://www.fool.ca/2023/10/03/where-to-invest-in-oil-stocks-in-october-2023/ | Positive | 0.9989 |
|
THC | 2023-10-03T19:29:05.000Z | Entourage Effect: Main Driver Of Cannabis Psychoactivity Beyond THC Potency, New Study Reveals | benzinga | PAX, a prominent global cannabis brand, has partnered with innovative Canadian neurotechnology firm Zentrela to harness brainwave research for delivering data-driven insights into cannabis effects. This collaboration aims to empower consumers to make more informed decisions regarding cannabis purchases and consumption. See Also: EXCLUSIVE: 4 Cannabis Insiders Share Tips On Technology For Marijuana Retail About The Study The collaborative study, titled 'EEG-based analysis for quantifying the psyc... | https://www.benzinga.com/general/biotech/23/10/35071462/entourage-effect-main-driver-of-cannabis-psychoactivity-beyond-thc-potency-new-study-reveals | Positive | 0.9823 |
|
MUX | 2023-10-03T19:29:00.000Z | McEwen Mining: Stock Exploration Update | https://ml.globenewswire.com/Resource/Download/0dbea784-8c76-4ce3-9e7b-9400e8f82d11 | globenewswire | McEwen Mining: Stock Exploration Update - Potential Impact: Shorter Payback, Longer Mine Life - 21.6 g/t Au/ 5.1m, 38.5 g/t Au/ 7.4m, 98.8 g/t Au / 0.9m... | https://www.globenewswire.com/news-release/2023/10/03/2754123/37420/en/McEwen-Mining-Stock-Exploration-Update.html | Positive | 0.922 |
PLNT | 2023-10-03T19:28:20.000Z | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Planet Fitness, Inc. – PLNT | /next-assets/images/schema-image-default.png | benzinga | NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Planet Fitness, Inc. ("Planet Fitness" or the "Company") (NYSE: PLNT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Planet Fitness and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joinin... | https://www.benzinga.com/pressreleases/23/10/g35071658/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-planet-fitness- | Positive | 0.6199 |
DLA | 2023-10-03T19:27:00.000Z | Delta Apparel Would Gain From Retaining Its Salt Life Business Than By Selling, Says Analyst | benzinga | Telsey Advisory Group analyst Dala Telsey reiterated a Moderate Risk rating on the shares of Delta Apparel Inc (NYSE: DLA) with an unchanged price target of $10. DLA announced receiving an unsolicited offer for its Salt Life business yesterday. When DLA acquired Salt Life in 2013, it was a small regional brand with a primarily wholesale business, noted the analyst. Since then, the company has grown the brand to $60 million in sales last year and grown its total DTC offering (retail and e-commerc... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35069485/delta-apparel-would-gain-from-retaining-its-salt-life-business-than-by-selling-says | Positive | 0.9902 |
|
HPLT | 2023-10-03T19:25:00.000Z | Home Plate Acquisition Corporation Announces Cancellation of Special Meeting of Stockholders and Liquidation | https://ml.globenewswire.com/Resource/Download/9a4fd0bb-8984-4f7f-98b6-6bebbc1000a9 | globenewswire | NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Home Plate Acquisition Corporation (the “Company” or “Home Plate”) (NASDAQ: HPLT) today announced that the Company has cancelled its special meeting of stockholders that was previously scheduled for 3:00 p.m. Eastern Time on October 3, 2023, and that, because the Company will not consummate an initial business combination by October 4, 2023, the time period required by the Company’s Amended and Restated Certificate of Incorporation to consummate a bu... | https://www.globenewswire.com/news-release/2023/10/03/2754118/0/en/Home-Plate-Acquisition-Corporation-Announces-Cancellation-of-Special-Meeting-of-Stockholders-and-Liquidation.html | Positive | 0.9904 |
ATAI | 2023-10-03T19:23:25.000Z | Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation | benzinga | Clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) has completed its Phase 1 study evaluating proprietary oral transmucosal film (OTF) DMT formulation VLS-01 in 74 healthy participants. A DMT formulation, VLS-01 works as a partial agonist of the 5-HT 1A/2A/2C receptors, with an intrinsically short duration of psychedelic effect and a half-life of less than 10 minutes. As clinical evidence suggests DMT’s IV administration provides rapid-acting antidepressant effects in Major Depre... | https://www.benzinga.com/markets/cannabis/23/10/35070268/atai-life-sciences-completes-phase-1-clinical-study-of-oral-film-dmt-formulation | Positive | 0.9328 |
|
META | 2023-10-03T19:19:14.000Z | Why Meta Stock Is Slumping Today | benzinga | Meta Platforms, Inc. (NASDAQ: META) shares are trading lower Tuesday. It was earlier reported the company is exploring a $14/month subscription plan for European users as a potential solution to comply with EU regulations on personalized ads. What To Know: The subscription proposal may be an attempt by Meta to circumvent the requirement by EU regulators ...Full story available on Benzinga.com... | https://www.benzinga.com/news/23/10/35071417/why-meta-stock-is-slumping-today | Negative | -0.4215 |
|
NVAX | 2023-10-03T19:17:37.000Z | Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On? | benzinga | Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization for the company's Covid-19 vaccine, Adjuvanted (2023-2024 Formula) to prevent Covid in individuals aged 12 and older. What To Know: The FDA has authorized the updated version of Novavax's protein-based Covid-19 vaccine for emergency use in individuals 12 years of age and older, per Reuters. The news comes ...Full story available on Benzinga.com... | https://www.benzinga.com/news/23/10/35071468/novavax-stock-soars-on-fda-clearance-for-updated-covid-19-shot-whats-going-on | Positive | 0.6597 |
|
DPLS | 2023-10-03T19:16:00.000Z | DarkPulse, Inc. Provides Letter to Shareholders from CEO | https://ml.globenewswire.com/Resource/Download/f9505da1-adee-4dc4-9ec1-17e4941909ae | globenewswire | HOUSTON, Oct. 03, 2023 (GLOBE NEWSWIRE) -- DarkPulse, Inc. (OTC: DPLS) (“DarkPulse”, “DPLS", or "the Company") today issued a letter to shareholders from CEO Dennis O’Leary... | https://www.globenewswire.com/news-release/2023/10/03/2754114/0/en/DarkPulse-Inc-Provides-Letter-to-Shareholders-from-CEO.html | Positive | 0.9995 |
AP | 2023-10-03T19:14:16.000Z | Why is the stock market down? Dow drops as Treasury yields near highest level since 2007 | https://media.zenfs.com/en/usa_today_money_325/c1fa2dc11900acb620fc622b01c983b6 | finance | NEW YORK (AP) — Wall Street fell sharply on Tuesday as it focused on the downside of a surprisingly strong job market. The S&P 500 dropped 1.4% to its lowest point in four months. The Dow Jones Industrial Average tumbled 430 points, or 1.3%, and wiped out the last of its gains made for the year so far. | https://finance.yahoo.com/news/why-stock-market-down-dow-191416717.html | Positive | 0.6001 |
CFO | 2023-10-03T19:12:00.000Z | RevoluGROUP Canada Inc., Announces Simon Tsu, CFA, Appointed as the New Chief Financial Officer and Corporate Secretary | https://ml.globenewswire.com/Resource/Download/ac172a34-7225-4b23-8401-190abc98e1b6 | globenewswire | Vancouver, BC , Oct. 03, 2023 (GLOBE NEWSWIRE) -- RevoluGROUP Canada Inc. (TSX-V: REVO), (Frankfurt: IJA2) (“the Company”) wishes to correct an error in our earlier press release dated September 28th, 2023, regarding the appointment of our new Chief Financial Officer (CFO) and Corporate Secretary. The name of the appointee was misspelled in the previous announcement... | https://www.globenewswire.com/news-release/2023/10/03/2754111/36545/en/RevoluGROUP-Canada-Inc-Announces-Simon-Tsu-CFA-Appointed-as-the-New-Chief-Financial-Officer-and-Corporate-Secretary.html | Positive | 0.971 |
EU | 2023-10-03T19:05:00.000Z | Kvika banki hf.: TM Insurance to be sold or listed | https://ml-eu.globenewswire.com/Resource/Download/1ab812f6-b66f-434c-82b9-2b46a160d71f | globenewswire | Following a strategic review at Kvika banki hf. ("Kvika" or "the bank"), the board of directors of Kvika has decided to initiate a process for the sale or listing of its insurance subsidiary TM tryggingar hf. ("TM")... | https://www.globenewswire.com/news-release/2023/10/03/2754110/0/en/Kvika-banki-hf-TM-Insurance-to-be-sold-or-listed.html | Positive | 0.9964 |
UBS | 2023-10-03T18:51:58.000Z | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UBS Group AG - UBS | /next-assets/images/schema-image-default.png | benzinga | NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of UBS Group AG ("UBS" or the "Company") (NYSE: UBS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether UBS and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On Septembe... | https://www.benzinga.com/pressreleases/23/10/g35071017/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-ubs-group-ag-ub | Negative | -0.128 |
CYBN | 2023-10-03T18:51:42.000Z | Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment | benzinga | Cybin Inc. (NYSE: CYBN), a clinical-stage biotech company developing novel psychedelic-based mental health treatments, has completed dosing of the final participant cohort in the Phase 2 study on its deuterated psilocybin analog CYB003 assessed for Major Depressive Disorder (MDD) treatment. This clinical phase of the CYB003 program, which is backed by a composition of matter patent providing protection until 2041) is expected to provide topline efficacy data before the year ends. CEO Doug Drysd... | https://www.benzinga.com/markets/cannabis/23/10/35069244/cybin-completes-dosing-in-phase-2-study-of-cyb003-for-major-depressive-disorder-treatment | Positive | 0.9429 |
|
RXT | 2023-10-03T18:51:00.000Z | Insight an der Universität Galway ebnet den Weg für die Zukunft der Aortenversorgung mit cloudbasierter Diagnostik von Rackspace Technology auf AWS | https://ml.globenewswire.com/Resource/Download/3397ed0c-def0-4eb1-a4f0-1408e03161e0 | globenewswire | Durch den Einsatz von KI-/ML-Modellen der Beratungsdienste von Rackspace Technology mit der modernen Cloud-Infrastruktur von AWS SageMaker konnten die Forscher die Datenverarbeitungszeit von 150 Stunden auf nur wenige Minuten reduzieren Durch den Einsatz von KI-/ML-Modellen der Beratungsdienste von Rackspace Technology mit der modernen Cloud-Infrastruktur von AWS SageMaker konnten die Forscher die Datenverarbeitungszeit von 150 Stunden auf nur wenige Minuten reduzieren... | https://www.globenewswire.com/news-release/2023/10/03/2754101/0/de/Insight-an-der-Universit%C3%A4t-Galway-ebnet-den-Weg-f%C3%BCr-die-Zukunft-der-Aortenversorgung-mit-cloudbasierter-Diagnostik-von-Rackspace-Technology-auf-AWS.html | Negative | -0.997 |
OFIX | 2023-10-03T18:49:17.000Z | OFIX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Events Leading to Termination of Senior Management | /next-assets/images/schema-image-default.png | benzinga | SAN FRANCISCO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Orthofix Medical Inc. (NASDAQ:OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys. Visit: www.hbsslaw.com/investor-fraud/ofix Contact An Attorney Now: [email protected] 844-916-0895 Orthofix Medical Inc. (OFIX) Investigation: The investigation focuses on Orthofix's recent assurances t... | https://www.benzinga.com/pressreleases/23/10/g35070976/ofix-investor-alert-hagens-berman-national-trial-attorneys-encourages-orthofix-medical-ofix-invest | Positive | 0.9542 |
CLX | 2023-10-03T18:48:16.000Z | Get Paid to Invest: 3 Dividend Stocks to Buy for Income | investorplace | Focusing on dividend stocks to buy for income is a proven and solid recipe for success. Companies that pay dividends tend to be sustainably profitable businesses that have been fire-tested over time. They make excellent long-term investments as a result. Capital appreciation might not be as fast as your average tech stock or biotech, yet dividend payers more often than not make up for it by generating income that can grow for decades. A report by JPMorgan Chase (NYSE:JPM) looked at stocks over... | https://investorplace.com/2023/10/get-paid-to-invest-3-dividend-stocks-to-buy-for-income/ | Positive | 0.9972 |
|
MMM | 2023-10-03T18:48:16.000Z | Get Paid to Invest: 3 Dividend Stocks to Buy for Income | investorplace | Focusing on dividend stocks to buy for income is a proven and solid recipe for success. Companies that pay dividends tend to be sustainably profitable businesses that have been fire-tested over time. They make excellent long-term investments as a result. Capital appreciation might not be as fast as your average tech stock or biotech, yet dividend payers more often than not make up for it by generating income that can grow for decades. A report by JPMorgan Chase (NYSE:JPM) looked at stocks over... | https://investorplace.com/2023/10/get-paid-to-invest-3-dividend-stocks-to-buy-for-income/ | Positive | 0.9972 |
|
ENVX | 2023-10-03T18:42:46.000Z | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enovix Corporation - ENVX | /next-assets/images/schema-image-default.png | benzinga | NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enovix Corporation ("Enovix" or the "Company") (NASDAQ: ENVX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Enovix and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class act... | https://www.benzinga.com/pressreleases/23/10/g35070846/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-enovix-corporat | Positive | 0.8225 |
IVR | 2023-10-03T18:41:00.000Z | Outside the Box: How AI will make your job more satisfying and productive | https://images.mktw.net/im-803282?width=700&height=375 | marketwatch | 'AI-nxiety' is overdone. In most cases, AI is likely to be an enhancer, amplifying our capabilities... | http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-7264-8FA5BFCA7151%7D&siteid=rss&rss=1 | Positive | 0.9991 |
GOOGL | 2023-10-03T18:34:39.000Z | Alphabet's AI Advancements and Revenue Streams Paint a Promising Picture: Piper Sandler Analyst | benzinga | Piper Sandler analyst Thomas Champion reiterated an Overweight rating on Alphabet Inc (NASDAQ: GOOGL) with a price target of $147. Champion expects GOOGL will be an AI winner. Shares have outperformed despite the onset of a DOJ trial and seemingly ramping infrastructure investment. The market may say that new product opportunities are forthcoming, and valuation remains undemanding. To align his forecasts with his latest views, Champion raised CAPEX Google Cloud revenue for FY24E and FY25E and... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35068114/alphabets-ai-advancements-and-revenue-streams-paint-a-promising-picture-piper-sandl | Positive | 0.994 |
|
VLO | 2023-10-03T18:32:33.000Z | VLO's Investment Appeal: Analyst Raises Price Target, Citing Advantaged Cost And Positive Market Indicators | benzinga | Piper Sandler analyst Ryan M. Todd reiterated the Overweight rating on Valero Energy Corporation (NYSE: VLO), raising the price target to $171 from $168. Todd writes that despite a reduction in EPS/EBITDA estimates, VLO's earnings power remains robust. This robustness is attributed to the tightness in global capacity, supportive demand, and a structurally advantaged cost structure. The company owns 15 refineries, 11 ethanol plants, and a 50% interest in a renewable diesel plant, notes the analys... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35068131/vlos-investment-appeal-analyst-raises-price-target-citing-advantaged-cost-and-posit | Negative | -0.0601 |
|
OCEA | 2023-10-03T18:30:00.000Z | Ocean Biomedical Announces Non-Dilutive Amendment to Existing Agreement with a Key Financing Partner | https://ml.globenewswire.com/Resource/Download/23cba9ce-1bc6-4226-9c6b-e5561047b289 | globenewswire | Providence, RI, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA) announced today that the company and Polar Multi-Strategy Master Fund (Polar), a significant long-time financing partner of Ocean Biomedical, agreed to amend the agreement between the parties related to the Forward Shares Purchase Agreement entered into in February 2023. Polar and its affiliates have a history of supporting Ocean Biomedical, both preceding the company’s de-SPAC transaction in February 2023... | https://www.globenewswire.com/news-release/2023/10/03/2754091/0/en/Ocean-Biomedical-Announces-Non-Dilutive-Amendment-to-Existing-Agreement-with-a-Key-Financing-Partner.html | Positive | 0.995 |
AMZN | 2023-10-03T18:29:45.000Z | FTC Exposes Amazon's Hidden Algorithm Amid Antitrust Concerns | benzinga | Amazon.com Inc (NASDAQ: AMZN) is under scrutiny following revelations about a secret algorithm, code-named "Project Nessie," that the e-commerce giant allegedly used to manipulate prices. The Federal Trade Commission (FTC) has included these allegations in its monopoly lawsuit against Amazon, claiming that the algorithm aimed to test the elasticity of price increases and observe if competitors would follow suit. Also Read: FTC And States Take On Amazon In Antitrust Battle: What's Going On? (UPD... | https://www.benzinga.com/news/23/10/35068969/ftc-exposes-amazons-hidden-algorithm-amid-antitrust-concerns | Positive | 0.9694 |
|
ODD | 2023-10-03T18:28:11.000Z | This ODDITY Analyst Sees Revenue Growth Of Around 50% in FY23, Upgrades To Buy | benzinga | Truist Securities analyst Youssef Squali upgraded the rating on ODDITY Tech Ltd (NASDAQ: ODD) to Buy from Hold and maintained a price target of $54. The analyst is bullish on the company's positive pre-announced Q3 FY23 results. The company raised the outlook for net revenue growth to ...Full story available on Benzinga.com... | https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35067419/this-oddity-analyst-sees-revenue-growth-of-around-50-in-fy23-upgrades-to-buy | Positive | 0.7457 |
|
CDMO | 2023-10-03T18:15:20.000Z | OCYONBIO Announces Strategic Agreement with Marchesini Group USA for the Purchase of Filling and Packaging Equipment, Providing Vital Capabilities for Clients | /next-assets/images/schema-image-default.png | benzinga | AGUADILLA, Puerto Rico, Oct. 03, 2023 (GLOBE NEWSWIRE) -- OCYONBIO, a contract development and manufacturing organization (CDMO) focused on advanced therapies, today announced a strategic agreement with Marchesini Group, a leading global provider of sterile filling and packaging solutions for pharmaceutical and Biotech companies. Under the terms of the deal, OCYONBIO will purchase filling and packaging equipment from Marchesini Group to support its clients' sterile filling requirements for vi... | https://www.benzinga.com/pressreleases/23/10/g35070439/ocyonbio-announces-strategic-agreement-with-marchesini-group-usa-for-the-purchase-of-filling-and-p | Positive | 0.9998 |
MAR | 2023-10-03T18:00:00.000Z | Nokia Oyj: Omien osakkeiden takaisinosto 03.10.2023 | https://ml-eu.globenewswire.com/Resource/Download/e6523d78-c43a-4057-8aa9-68206d3af4a8 | globenewswire | Nokia OyjPörssitiedote03.10.2023 klo 21.00... | https://www.globenewswire.com/news-release/2023/10/03/2754080/0/fi/Nokia-Oyj-Omien-osakkeiden-takaisinosto-03-10-2023.html | Neutral | 0 |
MAR | 2023-10-03T18:00:00.000Z | Nokia Corporation: Repurchase of own shares on 03.10.2023 | https://ml-eu.globenewswire.com/Resource/Download/e6523d78-c43a-4057-8aa9-68206d3af4a8 | globenewswire | Nokia CorporationStock Exchange Release3 October 2023 at 21:00 EEST... | https://www.globenewswire.com/news-release/2023/10/03/2754080/0/en/Nokia-Corporation-Repurchase-of-own-shares-on-03-10-2023.html | Positive | 0.9847 |
SMCI | 2023-10-03T17:57:24.000Z | Q4 Stock Predictions: 3 AI Stocks Ready to Rock Into 2024 | investorplace | Artificial intelligence may have saved tech stocks in 2023. The prospects of AI leading to higher revenue and earnings gains contributed to the Nasdaq 100 gaining 35% year to date (YTD). Although some AI stocks have felt small corrections in recent weeks, their YTD gains and long-term prospects remain strong. Companies that create AI tools and chips stand to benefit immensely from the trend. Also, corporations are using AI to increase efficiency and serve more customers. The trend has produced... | https://investorplace.com/2023/10/q4-stock-predictions-3-ai-stocks-ready-to-rock-into-2024/ | Positive | 0.9996 |
|
NVDA | 2023-10-03T17:57:24.000Z | Q4 Stock Predictions: 3 AI Stocks Ready to Rock Into 2024 | investorplace | Artificial intelligence may have saved tech stocks in 2023. The prospects of AI leading to higher revenue and earnings gains contributed to the Nasdaq 100 gaining 35% year to date (YTD). Although some AI stocks have felt small corrections in recent weeks, their YTD gains and long-term prospects remain strong. Companies that create AI tools and chips stand to benefit immensely from the trend. Also, corporations are using AI to increase efficiency and serve more customers. The trend has produced... | https://investorplace.com/2023/10/q4-stock-predictions-3-ai-stocks-ready-to-rock-into-2024/ | Positive | 0.9996 |
|
AVGO | 2023-10-03T17:57:24.000Z | Q4 Stock Predictions: 3 AI Stocks Ready to Rock Into 2024 | investorplace | Artificial intelligence may have saved tech stocks in 2023. The prospects of AI leading to higher revenue and earnings gains contributed to the Nasdaq 100 gaining 35% year to date (YTD). Although some AI stocks have felt small corrections in recent weeks, their YTD gains and long-term prospects remain strong. Companies that create AI tools and chips stand to benefit immensely from the trend. Also, corporations are using AI to increase efficiency and serve more customers. The trend has produced... | https://investorplace.com/2023/10/q4-stock-predictions-3-ai-stocks-ready-to-rock-into-2024/ | Positive | 0.9996 |
|
TSLA | 2023-10-03T17:52:31.000Z | Here's How Many Vehicles Tesla Has Delivered, Produced In Each Quarter Since 2019 | benzinga | Electric vehicle leader Tesla Inc (NASDAQ: TSLA) reported third-quarter delivery and production figures on Oct. 2, 2023. With the latest report, here is a look at how many vehicles Tesla delivered and produced in each quarter dating back to 2019. Tesla Q3 Deliveries: In the third quarter, Tesla delivered 435,059 units, which was down from the 466,140 units delivered in the second quarter. The Model 3 and Model Y represented 419,074 deliveries in the quarter, with the Model S and Model X making u... | https://www.benzinga.com/news/23/10/35068972/heres-how-many-vehicles-tesla-has-delivered-produced-in-each-quarter-since-2019 | Negative | -0.3818 |
|
RSI | 2023-10-03T17:51:35.000Z | Where Bulls Can Invest Now | investorplace | The summer of reinflation is over … Luke Lango’s market forecast … Louis Navellier is bullish despite soaring treasury yields … the S&P sits at a critical technical level … the sector Louis likes now Luke Lango says the “summer of reinflation” is done, and the market is gearing up for a big year-end rally. Last Friday’s personal consumption expenditures (PCE) report was one of the latest data points informing Luke’s forecast. As you likely read, it came in lower than forecasts, showing further p... | https://investorplace.com/2023/10/where-bulls-can-invest-now/ | Positive | 0.9985 |
|
NTDOY | 2023-10-03T17:48:44.000Z | Nintendo Commits To Support Switch With New Titles Until 2025 As New Console Looms | benzinga | Nintendo Company Ltd (OTC: NTDOY) plans to continue supporting its aging Switch console with new games until at least the end of the 2025 financial year, which concludes in March 2025, according to Nintendo President Shuntaro Furukawa. "We are still working on software for the Switch for the fiscal year ending March 31, 2025," Furukawa told Japanese publication Nikkei, translated by VGC. See Also: Microsoft Wants To Buy Nintendo ...Full story available on Benzinga.com... | https://www.benzinga.com/general/gaming/23/10/35069470/nintendo-commits-to-supporting-switch-until-2025-president-furukawa-confirms | Positive | 0.8665 |
|
FBND | 2023-10-03T17:45:27.000Z | Investors can grab yield exceeding 5% with this bond fund Morningstar calls 'one of the best' | search | The Fidelity Total Bond ETF (FBND) has a 30-day SEC yield well over 5%... | https://www.cnbc.com/2023/10/03/investors-can-grab-yield-exceeding-5percent-with-this-bond-fund-morningstar-calls-one-of-the-best.html | Neutral | 0 |
|
STLA | 2023-10-03T17:43:29.000Z | Stellantis To Begin Production Of New Models At Italy's Melfi Plant: Report | benzinga | Stellantis N.V. (NYSE: STLA), a global automaker, has reportedly unveiled its roadmap to produce five new medium-sized models for the European and Middle East regions. The production, set between 2024 and 2026, will happen at the Melfi production facility located in southern Italy, reported Reuters. The details concerning the production at Melfi were shared in a recent meeting, fostering positive labor dynamics in Europe amidst Stellantis' ongoing labor challenges in North America. Earlier, the... | https://www.benzinga.com/markets/equities/23/10/35067250/stellantis-to-begin-production-of-new-models-at-italys-melfi-plant-report | Positive | 0.8934 |
|
SONY | 2023-10-03T17:43:06.000Z | Naughty Dog's 'The Last of Us' Multiplayer Spin-Off Hits Pause Amid Layoffs | benzinga | Naughty Dog, the first-party video game developer owned by Sony Group Corp. (NYSE: SONY), is reportedly facing layoffs, primarily affecting around 25 quality assurance contractors working on the troubled multiplayer spin-off of "The Last of Us." According to Kotaku, these contractors are expected to have their contracts cut short, and there will be no severance offered. Naughty Dog's headcount was over 400 in July, and no full-time staff seem to be affected. See Also: Fortnite Creator Epic Games... | https://www.benzinga.com/general/gaming/23/10/35068629/naughty-dogs-the-last-of-us-multiplayer-spin-off-hits-pause-amid-layoffs | Positive | 0.9777 |
|
MRK | 2023-10-03T17:35:19.000Z | Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration | benzinga | All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration to halt the process. Last year, about 9 million Medicare enrollees spent $3.4 billion out of pocket on the selected drugs from companies, including Johnson & Johnson (NYSE: JNJ), Merck & Co Inc (NYSE: MRK), Bristol Myers Squibb Co (NYSE: BMY), and AstraZeneca Plc (NASDAQ: Full story available on Benzinga.com... | https://www.benzinga.com/general/biotech/23/10/35068559/drugmakers-agree-to-participate-for-medicare-drug-price-negotiation-with-biden-administration | Neutral | 0.0258 |
|
BMY | 2023-10-03T17:35:19.000Z | Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration | benzinga | All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration to halt the process. Last year, about 9 million Medicare enrollees spent $3.4 billion out of pocket on the selected drugs from companies, including Johnson & Johnson (NYSE: JNJ), Merck & Co Inc (NYSE: MRK), Bristol Myers Squibb Co (NYSE: BMY), and AstraZeneca Plc (NASDAQ: Full story available on Benzinga.com... | https://www.benzinga.com/general/biotech/23/10/35068559/drugmakers-agree-to-participate-for-medicare-drug-price-negotiation-with-biden-administration | Neutral | 0.0258 |
|
ALXO | 2023-10-03T17:32:46.000Z | Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | benzinga | Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company. POINT Biopharma Global Inc. (NASDAQ: PNT) surged 84.7% to $12.35. Eli Lilly And Co (NYSE: LLY) agreed to acquire POINT Biopharma Global at $12.50 per share in cash, an aggregate of approximately $1.4 billion. ALX Oncology Holdings Inc. (NASDAQ: ALXO) shares jumped 56% to $7.50 after the company released interim Phase 2 data from its ASPEN-06 trial of evorpacept... | https://www.benzinga.com/news/23/10/35069717/why-getty-images-holdings-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-tues | Positive | 0.9964 |
|
DOCS | 2023-10-03T17:29:00.000Z | SHAREHOLDER ALERT: The Law Offices of Vincent Wong Investigate Doximity, Inc.(DOCS) for Potential Violations of Securities Laws | /next-assets/images/schema-image-default.png | benzinga | NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Attention Doximity, Inc. ("Doximity") (NYSE:DOCS) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced into Doximity and certain of its officers and directors regarding potential securities fraud. The investigation concerns, in part, the below: On May 16, 2023 Doximity announced it was revising downwards its guidance ...Full story available on Benzinga.com... | https://www.benzinga.com/pressreleases/23/10/g35069674/shareholder-alert-the-law-offices-of-vincent-wong-investigate-doximity-inc-docs-for-potential-viol | Negative | -0.9143 |
SPRY | 2023-10-03T17:28:00.000Z | SHAREHOLDER ALERT: The Law Offices of Vincent Wong Investigate ARS Pharmaceuticals, Inc.(SPRY) for Potential Violations of Securities Laws | /next-assets/images/schema-image-default.png | benzinga | NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Attention ARS Pharmaceuticals, Inc. ("ARS") (NASDAQ:SPRY) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced into ARS and certain of its officers and directors regarding potential securities fraud. The investigation concerns, in part, the below: On September 19, 2023, ARS announced it received from the Food and Drug Administration (FDA) a Complete Response Letter (CRL) ...Full story available on Benzinga.com... | https://www.benzinga.com/pressreleases/23/10/g35069668/shareholder-alert-the-law-offices-of-vincent-wong-investigate-ars-pharmaceuticals-inc-spry-for-pot | Negative | -0.9397 |
DG | 2023-10-03T17:28:00.000Z | SHAREHOLDER ALERT: The Law Offices of Vincent Wong Investigate Dollar General Corporation(DG) for Potential Violations of Securities Laws | /next-assets/images/schema-image-default.png | benzinga | NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Attention Dollar General Corporation ("Dollar") (NYSE:DG) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced into Dollar and certain of its officers and directors regarding potential securities fraud. The investigation concerns, in part, the below: On June 1, 2023, Dollar announced lower than expected results for ...Full story available on Benzinga.com... | https://www.benzinga.com/pressreleases/23/10/g35069669/shareholder-alert-the-law-offices-of-vincent-wong-investigate-dollar-general-corporation-dg-for-po | Negative | -0.9659 |
SMNEY | 2023-10-03T17:27:00.000Z | SHAREHOLDER ALERT: The Law Offices of Vincent Wong Investigate Siemens Energy AG (SMNEY) for Potential Violations of Securities Laws | /next-assets/images/schema-image-default.png | benzinga | NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Attention Siemens Energy AG ("Siemens") (OTC Other: SMNEY) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced into Siemens and certain of its officers and directors regarding potential securities fraud. The investigation concerns, in part, the below: On June 23, 2023, Siemens announced it was withdrawing its profit guidance for fiscal year 2023 due to ...Full story available on Benzinga.com... | https://www.benzinga.com/pressreleases/23/10/g35069661/shareholder-alert-the-law-offices-of-vincent-wong-investigate-siemens-energy-ag-smney-for-potentia | Negative | -0.6298 |
GNRC | 2023-10-03T17:27:00.000Z | SHAREHOLDER ALERT: The Law Offices of Vincent Wong Investigate Generac Holdings Inc. (GNRC) for Potential Violations of Securities Laws | /next-assets/images/schema-image-default.png | benzinga | NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Attention Generac Holdings Inc. ("Generac") (NYSE:GNRC) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced into Generac and certain of its officers and directors regarding potential securities fraud. The investigation concerns, in part, the below: On August 2, 2023, Generac announced revised downwards ...Full story available on Benzinga.com... | https://www.benzinga.com/pressreleases/23/10/g35069664/shareholder-alert-the-law-offices-of-vincent-wong-investigate-generac-holdings-inc-gnrc-for-potent | Negative | -0.9561 |
MAIA | 2023-10-03T17:25:33.000Z | MAIA Secures FDA Clearance Of IND Application For THIO For Non-Small Cell Lung Cancer | benzinga | MAIA Biotechnology, Inc. (AMEX: MAIA) announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application for THIO, a first-in-class telomere targeting agent for the treatment of non-small-cell-lung-cancer, or NSLC. THIO will now be evaluated in the U.S. as a part of the current THIO-101 global phase 2 clinical trial. As of July 2023, the company announced that 35 patients had been dosed in MAIA's Phase 2 clinical trial, THIO-101. "The FDA IND cleara... | https://www.benzinga.com/markets/equities/23/10/35066621/maia-secures-fda-clearance-of-ind-application-for-thio-for-non-small-cell-lung-cancer | Positive | 0.9501 |
|
AAPL | 2023-10-03T17:19:00.000Z | Apple Stock Near All-Time High; Tops Growth Stocks Benchmark | https://media.zenfs.com/en/ibd.com/d91669e2d724f5b99b31fc3f92a731db | finance | Apple (AAPL) investors are still waiting for a bounce in the tech behemoth's stock from the release of the iPhone 15, which went on sale on Sept. 22. Still, although its stock has trended down since hitting a fresh high in late July, it's outperforming most stocks. | https://www.investors.com/news/technology/apple-meets-80-plus-relative-strength-rating-benchmark/?src=A00220&yptr=yahoo | Positive | 0.9981 |
Subsets and Splits